Flinn Raises $20M to Develop AI-Driven Product Lifecycle Tools for Medtech and Pharma

Deal Summary

Flinn announced a $20 million fundraising round to accelerate development of artificial intelligence tools for product lifecycle management in the medtech and pharmaceutical sectors. The capital will be used to build AI-driven solutions that streamline design, compliance, and market launch processes. The round underscores growing investor interest in AI applications within healthcare.